134 related articles for article (PubMed ID: 3680603)
21. Premedication with sublingual or oral alprazolam in adults undergoing diagnostic upper gastrointestinal endoscopy.
Shavakhi A; Soleiman S; Gholamrezaei A; Khodadoostan M; Shavakhi S; Tahery A; Minakari M
Endoscopy; 2014 Aug; 46(8):633-9. PubMed ID: 24977401
[TBL] [Abstract][Full Text] [Related]
22. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
23. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
Fay MA; Sheth RD; Gidal BE
Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and physiologic effects of alprazolam after a single oral dose in healthy mares.
Wong DM; Davis JL; Alcott CJ; Hepworth-Warren KL; Galow-Kersh NL; Rice S; Coetzee JF
J Vet Pharmacol Ther; 2015 Jun; 38(3):301-4. PubMed ID: 25427652
[TBL] [Abstract][Full Text] [Related]
25. Alprazolam kinetics in patients with renal insufficiency.
Ochs HR; Greenblatt DJ; Labedzki L; Smith RB
J Clin Psychopharmacol; 1986 Oct; 6(5):292-4. PubMed ID: 3771810
[TBL] [Abstract][Full Text] [Related]
26. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.
Aronsson A; Fiala C; Stephansson O; Granath F; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2007 Jul; 22(7):1912-8. PubMed ID: 17488782
[TBL] [Abstract][Full Text] [Related]
28. Effect of food on absorption of chlordemethyldiazepam.
Bareggi SR; Pirola R; Truci G; Leva S; Smirne S
Arzneimittelforschung; 1988 Apr; 38(4):561-2. PubMed ID: 2900012
[TBL] [Abstract][Full Text] [Related]
29. Plasma concentrations following oral and sublingual administration of lorazepam.
Gram-Hansen P; Schultz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):323-4. PubMed ID: 3410611
[TBL] [Abstract][Full Text] [Related]
30. The pharmacology of alprazolam: a review.
Huybrechts I
Clin Ther; 1991; 13(1):100-17. PubMed ID: 2029716
[TBL] [Abstract][Full Text] [Related]
31. Arterial-venous plasma concentration differences of 6-chloro-2-pyridylmethyl nitrate in humans after sublingual administration.
Terada T; Ishibashi K; Tsuchiya T; Noguchi H; Sugiyama A; Nakashima M; Kanamaru M; Ishimura T
Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):331-9. PubMed ID: 2727387
[TBL] [Abstract][Full Text] [Related]
32. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
[TBL] [Abstract][Full Text] [Related]
33. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam.
Otani K; Yasui N; Furukori H; Kaneko S; Tasaki H; Ohkubo T; Nagasaki T; Sugawara K; Hayashi K
Int Clin Psychopharmacol; 1997 May; 12(3):153-7. PubMed ID: 9248872
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the interaction of lithium and alprazolam.
Evans RL; Nelson MV; Melethil S; Townsend R; Hornstra RK; Smith RB
J Clin Psychopharmacol; 1990 Oct; 10(5):355-9. PubMed ID: 2124219
[TBL] [Abstract][Full Text] [Related]
35. Alprazolam pharmacokinetics in women on low-dose oral contraceptives.
Scavone JM; Greenblatt DJ; Locniskar A; Shader RI
J Clin Pharmacol; 1988 May; 28(5):454-7. PubMed ID: 3392243
[TBL] [Abstract][Full Text] [Related]
36. Relative bioavailability of midazolam following sublingual versus oral administration in healthy volunteers.
Fujii J; Inotsume N; Nakano M
J Pharmacobiodyn; 1988 Mar; 11(3):206-9. PubMed ID: 3411438
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of alprazolam following single and multiple oral doses of a sustained-release formulation.
Fleishaker JC; Phillips JP; Eller MG; Smith RB
J Clin Pharmacol; 1989 Jun; 29(6):543-9. PubMed ID: 2754023
[TBL] [Abstract][Full Text] [Related]
38. Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam.
Furukori H; Otani K; Yasui N; Kondo T; Kaneko S; Shimoyama R; Ohkubo T; Nagasaki T; Sugawara K
Neuropsychopharmacology; 1998 May; 18(5):364-9. PubMed ID: 9536449
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration.
Smith RB; Kroboth PD; Vanderlugt JT; Phillips JP; Juhl RP
Psychopharmacology (Berl); 1984; 84(4):452-6. PubMed ID: 6152055
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
Greenblatt DJ; Wright CE
Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
